Phase 1 Trial for Chronic Plaque Psoriasis Treatment Launched by Exicure
News
Exicure, a company developing a new class of immunomodulatory and gene-silencing drugs including Spherical Nucleic Acid (SNA), has just announced the dosing of the first patient in its Phase 1 ... Read more